Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

Condition:   Melanoma Interventions:   Biological: Nivolumab;   Biological: Pembrolizumab;   Radiation: Radiation Therapy;   Biological: Therapeutic Exchange Plasma Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials